Defibrillator Market to Reach USD 16.44 Billion by 2030, Driven by Rising Cardiac Emergencies and Technological Advancements

Posted on by sadmin

The global Defibrillator Market, valued at USD 11.29 billion in 2024, is projected to rise to USD 11.99 billion in 2025 and continue on a steady growth trajectory to reach USD 16.44 billion by 2030, reflecting a CAGR of 6.5% during the forecast period. As cardiovascular diseases remain the leading cause of mortality worldwide, defibrillators have become critical life-saving tools across hospital, pre-hospital, and public settings. Increasing emphasis on emergency preparedness, rapid technological advancements, and widespread government initiatives are reshaping the market landscape, making defibrillators more accessible and more intelligent than ever before.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549

Market Overview: Growing Demand Amid Rising Cardiac Emergencies

The rising global burden of cardiovascular diseases (CVDs) is the primary driver of the defibrillator market. Conditions such as arrhythmias, sudden cardiac arrest (SCA), and congestive heart failure demand immediate and precise intervention—making defibrillators indispensable in both clinical and emergency settings.

Key contributors to market growth include:

  • Rising cases of sudden cardiac arrest, particularly among the aging population

  • Increasing installations of public-access defibrillators (PADs) in airports, malls, offices, and transportation hubs

  • Government-led training programs and community awareness initiatives

  • Growing investments in emergency healthcare infrastructure in emerging economies

  • Product innovations and partnerships among manufacturers to boost the availability of advanced defibrillation devices

The result is a robust market ecosystem where demand is increasing across both implantable and external defibrillator categories.

Market Segmentation Insights

By Product: ICDs Lead the Global Market

The defibrillator market is categorized into:

  • Implantable Cardioverter Defibrillators (ICDs)

  • External Defibrillators (Manual, Automated External Defibrillators or AEDs, and Wearable Cardioverter Defibrillators)

In 2024, the ICDs segment is expected to command the largest global market share. ICDs have gained strong clinical acceptance due to their ability to deliver timely, automated intervention during life-threatening arrhythmias. Rising adoption of subcutaneous ICDs (S-ICDs)—which reduce complications associated with transvenous leads—is further accelerating market growth.

Moreover, favorable regulatory approvals for technologically advanced ICDs and the increasing incidence of heart rhythm disorders are expected to propel the segment in coming years.

By End User: Hospitals & Clinics Dominate

End users in the defibrillator market include:

  • Hospitals & Clinics

  • Cardiac Centers

  • Pre-hospital Settings (EMS/Ambulances)

  • Public-Access Markets

  • Home Care Settings

  • Other End Users

In 2024, Hospitals & Clinics emerged as the dominant segment. This is attributed to:

  • Rising hospital admissions for acute cardiac conditions

  • Growing number of ICD and CRT-D implantation procedures

  • Increasing prevalence of cardiac diseases among elderly populations

  • Availability of trained professionals and advanced ICU/CCU infrastructure

Hospitals continue to be the primary point of care, especially for severe cardiac emergencies, ensuring consistent demand for advanced defibrillation systems.

Regional Insights: North America Leads, Asia Pacific Accelerates

The global defibrillator market is segmented into:

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East & Africa

North America: Largest Regional Market

North America held the largest share of the defibrillator market in 2024 due to:

  • High adoption of technologically advanced ICDs and AEDs

  • Favorable reimbursement frameworks

  • Strong presence of leading manufacturers

  • Large population with cardiovascular disease risk factors

  • Government emphasis on cardiac health and emergency response systems

The region’s robust infrastructure and rapid uptake of new technologies help sustain its leadership position.

Asia Pacific: Fastest-Growing Market

The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Key growth factors include:

  • A large, underserved patient population

  • Rising incidence of cardiac disorders

  • Government initiatives to modernize healthcare systems

  • Increasing investments from global market leaders expanding their APAC footprint

  • Growing adoption of PAD programs in countries like Japan, China, and South Korea

Emerging economies such as India and China present immense opportunities for defibrillator manufacturers.

Key Industry Players and Strategic Developments

Global competition in the defibrillator market is shaped by innovation, regulatory approvals, strategic partnerships, and regional expansion. Major companies include:

  • Medtronic (Ireland)

  • Stryker (US)

  • Koninklijke Philips N.V. (Netherlands)

  • Asahi Kasei Corporation (Japan)

  • Boston Scientific Corporation (US)

  • Abbott (US)

  • MicroPort Scientific Corporation (China)

  • Nihon Kohden Corporation (Japan)

  • Biotronik (Germany)

  • CU Medical Systems, Inc. (South Korea)

Below are highlights from leading companies:

Medtronic: The Global Leader in Implantable Defibrillators

Medtronic remains the top player in the global ICD market, backed by a broad portfolio and continuous innovation in cardiac rhythm management. The company prioritizes:

  • R&D investments

  • New product commercialization

  • Market expansion through acquisitions and partnerships

Medtronic recently received CE Mark approval for its Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan—next-generation implantable defibrillator systems designed to manage complex heart rhythm disorders. These regulatory milestones strengthen its position across Europe and global markets.

Koninklijke Philips N.V.: Leader in External Defibrillation

Philips is recognized globally for its widely adopted HeartStart AED series, known for reliability, intuitive design, and extensive use in both public and clinical environments. The company’s leadership is driven by:

  • Real-time guidance and smart prompts

  • Fast shock delivery

  • Seamless digital connectivity

  • Strong global distribution

Philips continues to advance the adoption of accessible AED solutions to support out-of-hospital cardiac arrest (OHCA) management.

Boston Scientific Corporation: Innovating Cardiac Rhythm Management

Boston Scientific focuses heavily on R&D and product launches in the cardiac rhythm management space. The company is known for:

  • MRI-compatible defibrillators

  • Next-generation implantable devices

  • Robust clinical research programs

Its ongoing innovations and regulatory approvals are expected to reinforce its competitive edge in the ICD segment.

Conclusion: A Market Poised for Steady Expansion

As cardiovascular diseases continue to rise and healthcare systems prioritize advanced emergency care, the global defibrillator market is positioned for strong and sustained growth. Technological advancements, increased public accessibility, and strategic industry collaborations will play a pivotal role in accelerating adoption across both developed and emerging economies.

With leading companies investing in next-generation devices and expanding their global reach, the defibrillator market is set to play an increasingly critical role in reducing cardiac-related mortality worldwide.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=549

©2025 Reportsnreports